NCT05673915 Study of Transcranial Direct Current Stimulation to Treat Epilepsy
| NCT ID | NCT05673915 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Focal Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-04-12 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-04-12 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.
Eligibility Criteria
Inclusion Criteria * Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy. * Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%. * Has not had control with at least 2 anti-seizure medicines. * Able to maintain a constant medication for duration of the study (rescue meds allowed). * Subject or legally authorized representative is able to understand consent and keep a seizure diary in English. Exclusion Criteria: * A disease likely to progress over course of the study. * Psychogenic non-epileptic seizures. * Suicide attempt or psychiatric hospitalization past 2 years. * A skin condition interfering with scalp electrodes or allergy to silver. * Women will verify not pregnant, and if applicable, have a serum pregnancy test. * Implanted devices (e.g. pacemakers)-except VNS, which is allowed.
Contact & Investigator
Brian Lundstrom, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05673915 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Focal Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05673915 currently recruiting?
Yes, NCT05673915 is actively recruiting participants. Contact the research team at ruiz.precylla@mayo.edu for enrollment information.
Where is the NCT05673915 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05673915 clinical trial?
NCT05673915 is sponsored by Mayo Clinic. The principal investigator is Brian Lundstrom, MD, PhD at Mayo Clinic. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.